nach oben

Obesity Surgery

Erschienen in:

23.10.2018 | Original Contributions

Technical Feasibility of a Murine Model of Sleeve Gastrectomy with Ileal Transposition

verfasst von: Lee D. Ying, Gregory A. Breuer, Matthew O. Hubbard, Geoffrey S. Nadzam, John Hwa, Kathleen A. Martin

Erschienen in: Obesity Surgery | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Sleeve gastrectomy with ileal transposition has been shown to be superior to sleeve gastrectomy alone for promoting weight loss in rat and porcine models. The absence of a mouse model for this procedure has impeded efforts to understand the molecular physiology underlying its efficacy. This study demonstrates the long-term survivability of sleeve gastrectomy with ileal transposition in mice.

Materials and Methods

In this study of technical feasibility, a sleeve gastrectomy with ileal transposition (SGIT), sleeve gastrectomy (SG), or sham surgery (SH) was performed on 7- to 8-week-old C57Bl/6J mice (n = 8 for each). To evaluate long-term survivability, mice were placed on an obesogenic diet and weighed weekly for 10 weeks. The intestinal identity of the transposed segment was assessed with gene expression analysis of duodenal-, jejunal-, and ileal-specific hormones using quantitative polymerase chain reaction.

Results

Overall, SGIT better prevented weight gain than the SG or sham procedures (10-week post-operative weight: SH 45.3 ± 1.0 g, SG 41.25 ± 1.6 g, SGIT 35.4 ± 0.8 g). Gene expression pattern analysis of three markers of intestinal identity (gastrin, cholecystokinin, and peptide YY) suggests that the ileal identity of the transposed segment is maintained 10 weeks after transposition.

Conclusions

We demonstrate for the first time a reproducible mouse model of sleeve gastrectomy with ileal transposition. Future studies utilizing this model will expand our understanding of the molecular pathways through which the hindgut regulates satiety.

Nur mit Berechtigung zugänglich

Flegal KM, Kruszon-Moran D, Carroll MD, et al. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315(21):2284–91. https://doi.org/10.1001/jama.2016.6458.CrossRef

Kelly T, Yang W, Chen CS, et al. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond). 2008;32:1431. https://doi.org/10.1038/ijo.2008.102. https://www.nature.com/articles/ijo2008102-supplementary-information CrossRef

Mendez MA, Monteiro CA, Popkin BM. Overweight exceeds underweight among women in most developing countries. Am J Clin Nutr. 2005;81(3):714–21.CrossRefPubMed

Haslam DW, James WPT. Obesity. Lancet. 2005;366(9492):1197–209. https://doi.org/10.1016/S0140-6736(05)67483-1.CrossRef

Andersen JR, Aasprang A, Karlsen T-I, et al. Health-related quality of life after bariatric surgery: a systematic review of prospective long-term studies. Surg Obes Relat Dis. 2015;11(2):466–73. https://doi.org/10.1016/j.soard.2014.10.027.CrossRefPubMed

Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222(3):339–52.CrossRefPubMedPubMedCentral

Picot J, Jones J, Colquitt JL, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess (Winch. Eng.). 2009;13(41):1–190,215–357, iii-iv. https://doi.org/10.3310/hta13410.CrossRef

Lopes EC, Heineck I, Athaydes G, et al. Is bariatric surgery effective in reducing comorbidities and drug costs? A systematic review and meta-analysis. Obes Surg. 2015;25(9):1741–9. https://doi.org/10.1007/s11695-015-1777-5.CrossRefPubMed

Maciejewski ML, Arterburn DE. Cost-effectiveness of bariatric surgery. JAMA. 2013;310(7):742–3. https://doi.org/10.1001/jama.2013.276131.CrossRefPubMedPubMedCentral

10.

Chang S, Stoll CT, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014;149(3):275–87. https://doi.org/10.1001/jamasurg.2013.3654.CrossRefPubMedPubMedCentral

11.

Almogy G, Crookes PF, Anthone GJ. Longitudinal gastrectomy as a treatment for the high-risk super-obese patient. Obes Surg. 2004;14(4):492–7. https://doi.org/10.1381/096089204323013479.CrossRefPubMed

12.

Silecchia G, Boru C, Pecchia A, et al. Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Obes Surg. 2006;16(9):1138–44. https://doi.org/10.1381/096089206778392275.CrossRefPubMed

13.

Surgery ASfMaB. Estimate of bariatric surgery numbers, 2011–2015. Am Soc Metab Bariatric Surg. 2016.

14.

Mann JP, Jakes AD, Hayden JD, et al. Systematic review of definitions of failure in revisional bariatric surgery. Obes Surg. 2015;25(3):571–4. https://doi.org/10.1007/s11695-014-1541-2.CrossRefPubMed

15.

Brethauer SA, Kothari S, Sudan R, et al. Systematic review on reoperative bariatric surgery: American Society for Metabolic and Bariatric Surgery Revision Task Force. Surg Obes Relat Dis. 2014;10(5):952–72. https://doi.org/10.1016/j.soard.2014.02.014.CrossRefPubMed

16.

Chansaenroj P, Aung L, Lee W-J, et al. Revision procedures after failed adjustable gastric banding: comparison of efficacy and safety. Obes Surg. 2017;27(11):2861–7. https://doi.org/10.1007/s11695-017-2716-4.CrossRefPubMed

17.

Kellogg TA. Revisional bariatric surgery. Surg Clin N Am. 2011;91(6):1353–71. https://doi.org/10.1016/j.suc.2011.08.004.CrossRefPubMed

18.

Khoursheed MA, Al-Bader IA, Al-asfar FS, et al. Revision of failed bariatric procedures to Roux-en-Y gastric bypass (RYGB). Obes Surg. 2011;21(8):1157–60. https://doi.org/10.1007/s11695-010-0229-5.CrossRefPubMed

19.

Noel P, Schneck A-S, Nedelcu M, et al. Laparoscopic sleeve gastrectomy as a revisional procedure for failed gastric banding: lessons from 300 consecutive cases. Surg Obes Relat Dis. 10(6):1116–22. https://doi.org/10.1016/j.soard.2014.02.045.

20.

Nesset EM, Kendrick ML, Houghton SG, et al. A two-decade spectrum of revisional bariatric surgery at a tertiary referral center. Surg Obes Relat Dis. 2007;3(1):25–30. https://doi.org/10.1016/j.soard.2006.10.010.CrossRefPubMed

21.

Hallowell PT, Stellato TA, Yao DA, et al. Should bariatric revisional surgery be avoided secondary to increased morbidity and mortality? Am J Surg. 2009;197(3):391–6. https://doi.org/10.1016/j.amjsurg.2008.11.011.CrossRefPubMed

22.

Knop FK, Taylor R. Mechanism of metabolic advantages after bariatric surgery: it’s all gastrointestinal factors versus it’s all food restriction. Diabetes Care. 2013;36(Suppl 2):S287–S91. https://doi.org/10.2337/dcS13-2032.CrossRefPubMedPubMedCentral

23.

Madura JA, DiBaise JK. Quick fix or long-term cure? Pros and cons of bariatric surgery. F1000 Med Rep. 2012;4:19. https://doi.org/10.3410/M4-19.CrossRefPubMedPubMedCentral

24.

Ionut V, Bergman RN. Mechanisms responsible for excess weight loss after bariatric surgery. J Diabetes Sci Technol. 2011;5(5):1263–82.CrossRefPubMedPubMedCentral

25.

Barreto SG, Soenen S, Chisholm J, et al. Does the ileal brake mechanism contribute to sustained weight loss after bariatric surgery? ANZ J Surg. 2018;88(1–2):20–5. Epub 2017/06/09. https://doi.org/10.1111/ans.14062.CrossRefPubMed

26.

Meek CL, Lewis HB, Reimann F, et al. The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones. Peptides. 2016;77:28–37. Epub 2015/09/08. https://doi.org/10.1016/j.peptides.2015.08.013.CrossRef

27.

Boza C, Muñoz R, Yung E, et al. Sleeve gastrectomy with ileal transposition (SGIT) induces a significant weight loss and diabetes improvement without exclusion of the proximal intestine. J Gastrointest Surg. 2011;15(6):928–34. https://doi.org/10.1007/s11605-010-1369-6.CrossRefPubMed

28.

Nausheen S, Shah IH, Pezeshki A, et al. Effects of sleeve gastrectomy and ileal transposition, alone and in combination, on food intake, body weight, gut hormones, and glucose metabolism in rats. Am J Physiol Endocrinol Metab. 2013;305(4):E507–18. https://doi.org/10.1152/ajpendo.00130.2013.CrossRefPubMed

29.

de Paula AL, Macedo ALV, Prudente AS, et al. Laparoscopic sleeve gastrectomy with ileal interposition (“neuroendocrine brake”)--pilot study of a new operation. Surg Obes Relat Dis. 2006;2(4):464–7. https://doi.org/10.1016/j.soard.2006.03.005.CrossRefPubMed

30.

Çelik A, Ugale S, Ofluoğlu H. Laparoscopic diverted resleeve with ileal transposition for failed laparoscopic sleeve gastrectomy: a case report. Surg Obes Relat Dis. 2015;11(1):e5–7. https://doi.org/10.1016/j.soard.2014.09.010.CrossRefPubMed

31.

DePaula AL, Macedo ALV, Mota BR, et al. Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21–29. Surg Endosc. 2009;23(6):1313–20. https://doi.org/10.1007/s00464-008-0156-x.CrossRefPubMed

32.

Kotler DP, Koopmans H. Preservation of intestinal structure and function despite weight loss produced by ileal transposition in rats. Physiol Behav. 1984;32(3):423–7. https://doi.org/10.1016/0031-9384(84)90257-9.CrossRefPubMed

33.

Boozer CN, Choban PS, Atkinson RL. Ileal transposition surgery attenuates the increased efficiency of weight gain on a high-fat diet. Int J Obes. 1990;14(10):869–78.PubMed

34.

Gleeson MH, Cullen J, Dowling RH. Intestinal structure and function after small bowel by-pass in the rat. Clin Sci. 1972;43(6):731–42.CrossRefPubMed

35.

Strader AD, Vahl TP, Jandacek RJ, et al. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab. 2005;288(2):E447.CrossRefPubMed

36.

Boza C, Gagner M, Devaud N, et al. Laparoscopic sleeve gastrectomy with ileal transposition (SGIT): a new surgical procedure as effective as gastric bypass for weight control in a porcine model. Surg Endosc. 2008;22(4):1029–34. https://doi.org/10.1007/s00464-007-9685-y.CrossRefPubMed

37.

Laboratories J. Body weight information for C57BL/6J.

38.

River C. SAS Sprague Dawley rat growth chart.

39.

Bruinsma BG, Uygun K, Yarmush ML, et al. Surgical models of Roux-en-Y gastric bypass surgery and sleeve gastrectomy in rats and mice. Nat Protoc. 2015;10(3):495–507. https://doi.org/10.1038/nprot.2015.027.CrossRefPubMedPubMedCentral

40.

Hao Z, Zhao Z, Berthoud H-R, et al. Development and verification of a mouse model for Roux-en-Y gastric bypass surgery with a small gastric pouch. PLoS One. 2013;8(1):e52922. https://doi.org/10.1371/journal.pone.0052922.CrossRefPubMedPubMedCentral

41.

Ayer A, Borel F, Moreau F, et al. Techniques of sleeve gastrectomy and modified Roux-en-Y gastric bypass in mice. J Vis Exp. 2017;121 https://doi.org/10.3791/54905.

42.

Seyfried F, Lannoo M, Gsell W, et al. Roux-en-Y gastric bypass in mice—surgical technique and characterisation. Obes Surg. 2012;22(7):1117–25. https://doi.org/10.1007/s11695-012-0661-9.CrossRefPubMed

43.

Lutz TA, Bueter M. The use of rat and mouse models in bariatric surgery experiments. Front Nutr. 2016;3(25) https://doi.org/10.3389/fnut.2016.00025.

44.

Hao Z, Townsend RL, Mumphrey MB, Morrison CD, Münzberg H, Berthoud H-R. RYGB produces more sustained body weight loss and improvement of glycemic control compared with VSG in the diet-induced obese mouse model 2017.

45.

Seyfried F, Lannoo M, Gsell W, Tremoleda JL, Bueter M, Olbers T, et al. Roux-en-Y gastric bypass in mice-surgical technique and characterisation 2012. 1117–1125 p.

46.

Du J, Tian J, Ding L, et al. Vertical sleeve gastrectomy reverses diet-induced gene-regulatory changes impacting lipid metabolism. Sci Report. 2017;7:5274. https://doi.org/10.1038/s41598-017-05349-2.CrossRef

47.

Ding L, Sousa Kyle M, Jin L, et al. Vertical sleeve gastrectomy activates GPBAR-1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice. Hepatology. 2016;64(3):760–73. https://doi.org/10.1002/hep.28689.CrossRefPubMedPubMedCentral

48.

Wilson-Pérez HE, Chambers AP, Ryan KK, et al. Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like peptide 1 receptor deficiency. Diabetes. 2013;62(7):2380–5. https://doi.org/10.2337/db12-1498.CrossRefPubMedPubMedCentral

49.

Pressler JW, Haller A, Sorrell J, et al. Vertical sleeve gastrectomy restores glucose homeostasis in apolipoprotein A-IV KO mice. Diabetes. 2015;64(2):498–507. https://doi.org/10.2337/db14-0825.CrossRefPubMed

50.

Shao Y, Shen Q, Hua R, et al. Effects of sleeve gastrectomy on the composition and diurnal oscillation of gut microbiota related to the metabolic improvements. Surg Obes Relat Dis. 2018; https://doi.org/10.1016/j.soard.2018.02.024.

51.

Stearns AT, Balakrishnan A, Tavakkolizadeh A. Impact of Roux-en-Y gastric bypass surgery on rat intestinal glucose transport. Am J Physiol Gastrointest Liver Physiol. 2009;297(5):G950–7.CrossRefPubMedPubMedCentral

52.

Maljaars PJ, Keszthelyi D, Masclee AA. An ileal brake-through? Am J Clin Nutr. 2010;92(3):467–8. https://doi.org/10.3945/ajcn.2010.30180.CrossRefPubMed

53.

Strader AD. Ileal transposition provides insight into the effectiveness of gastric bypass surgery. Physiol Behav. 2006;88(3):277–82. https://doi.org/10.1016/j.physbeh.2006.05.034.CrossRefPubMed

54.

Maljaars PW, Symersky T, Kee BC, et al. Effect of ileal fat perfusion on satiety and hormone release in healthy volunteers. Int J Obes (Lond). 2008;32(11):1633–9. https://doi.org/10.1038/ijo.2008.166.CrossRef

55.

Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab. 2004;89(6):2608–15. https://doi.org/10.1210/jc.2004-0433.CrossRefPubMed

56.

Mason EE. The mechanisms of surgical treatment of type 2 diabetes. Obes Surg. 2005;15(4):459–61. https://doi.org/10.1381/0960892053723330.CrossRefPubMed

57.

Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244(5):741–9. https://doi.org/10.1097/01.sla.0000224726.61448.1b.CrossRefPubMedPubMedCentral

Titel: Technical Feasibility of a Murine Model of Sleeve Gastrectomy with Ileal Transposition
verfasst von: Lee D. Ying
Gregory A. Breuer
Matthew O. Hubbard
Geoffrey S. Nadzam
John Hwa
Kathleen A. Martin
Publikationsdatum: 23.10.2018
Verlag: Springer US
Erschienen in: Obesity Surgery / Ausgabe 2/2019
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-018-3555-7

Neu im Fachgebiet Chirurgie

Wie sieht der OP der Zukunft aus?

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Recycling im OP – möglich, aber teuer

02.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO₂-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Background

Materials and Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Bariatric Surgery Did Not Increase the Risk of Gallstone Disease in Obese Patients: a Comprehensive Cohort Study

Multimodal Postoperative Pain Control Is Effective and Reduces Opioid Use After Laparoscopic Roux-en-Y Gastric Bypass

A New Protocol for Venous Thromboembolism Prophylaxis in Bariatric Surgery

Less Morbidity with Robot-Assisted Gastric Bypass Surgery than with Laparoscopic Surgery?

Short-Term Outcomes of Conversion of Failed Gastric Banding to Laparoscopic Sleeve Gastrectomy or Roux-En-Y Gastric Bypass: a Meta-Analysis

Invited Response Letter: Our Experience Regarding the Association Between Gastrointestinal Stromal Tumor and Bariatric Surgery. A Response to a Letter “Gastrointestinal Stromal Tumor After Laparoscopic Sleeve Gastrectomy: Be Awake Before, During, and After a Bariatric Procedure”

Update Chirurgie